Brightangeltherapeutics
Toronto, CA · 2 known investors
Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing small-molecule antifungal therapeutics aimed at drug-resistant and life-threatening invasive fungal infections. It designs fungal-selective inhibitors targeting fungal stress responses, using Schrödinger's computational drug discovery platform alongside its own proprietary technologies.
Founders & leadership
LC
Leah CowenCo-founder & CSO
LW
Luke WhitesellCo-founder & Consultant
DJ
Dominic JaikaranPresident & CEO
Investors · 2
Frequently asked questions
- What does Brightangeltherapeutics do?
- Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing small-molecule antifungal therapeutics aimed at drug-resistant and life-threatening invasive fungal infections. It designs fungal-selective inhibitors targeting fungal stress responses, using Schrödinger's computational drug discovery platform alongside its own proprietary technologies.
- Who founded Brightangeltherapeutics?
- Brightangeltherapeutics was founded by Leah Cowen, Luke Whitesell.
- Who are Brightangeltherapeutics's investors?
- Brightangeltherapeutics's investors include Lumira Ventures, Toronto Innovation Acceleration Partners.
- Where is Brightangeltherapeutics headquartered?
- Brightangeltherapeutics is headquartered in Toronto, CA.